Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.42 |
| ▸ | TAS2R31 | P59538 | 1/20 | 0.39 |
| ▸ | UGT2B7 | P16662 | 5/20 | 0.38 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | TTL | Q8NG68 | 3/20 | 0.35 |
| ▸ | PNLIP | P16233 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10524433 | 1.00 | ALDH1A1 (0.54) | ALDH1A1MEN1CYP3A4MAPTKMT2A | |
| SCHEMBL10524625 | 1.00 | ALDH1A1 (0.54) | ALDH1A1MEN1CYP3A4MAPTKMT2A | |
| SCHEMBL23868641 | 0.87 | ALDH1A1 (0.57) | ALDH1A1MEN1CYP3A4MAPTKMT2A | |
| SCHEMBL13987815 | 0.87 | ALDH1A1 (0.57) | ALDH1A1MEN1CYP3A4MAPTKMT2A | |
| SCHEMBL25666845 | 0.87 | ALDH1A1 (0.57) | ALDH1A1MEN1CYP3A4MAPTKMT2A | |
| SCHEMBL16816911 | 0.85 | ALDH1A1 (0.60) | ALDH1A1MEN1CYP3A4MAPTKMT2A | |
| SCHEMBL18949251 | 0.85 | ALDH1A1 (0.60) | ALDH1A1MEN1CYP3A4MAPTKMT2A | |
| SCHEMBL16984792 | 0.85 | ALDH1A1 (0.60) | ALDH1A1MEN1CYP3A4MAPTKMT2A | |
| SCHEMBL16816912 | 0.85 | ALDH1A1 (0.60) | ALDH1A1MEN1CYP3A4MAPTKMT2A | |
| SCHEMBL18216691 | 0.85 | ALDH1A1 (0.60) | ALDH1A1MEN1CYP3A4MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8921417-B2 | Method of treating dyslipidemia using naturally occurring diterpene | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2014-12-30 | — | — | US | disclosed |
| US-20090247626-A1 | Method of Treating Dyslipidemia Using Naturally Occurring Diterpene | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2009-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090247626-A1 | Method of Treating Dyslipidemia Using Naturally Occurring Diterpene | DHCR7, LSS, HMGCR | ALDH1A1 3654/4885MEN1 3173/4885CYP3A4 1860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.